BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//The National Drug Abuse Treatment Clinical Trials Network - Northeast Node - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:The National Drug Abuse Treatment Clinical Trials Network - Northeast Node
X-ORIGINAL-URL:https://www.ctnnortheastnode.org
X-WR-CALDESC:Events for The National Drug Abuse Treatment Clinical Trials Network - Northeast Node
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230214T120000
DTEND;TZID=America/New_York:20230214T130000
DTSTAMP:20260405T162649
CREATED:20230210T164844Z
LAST-MODIFIED:20230210T164844Z
UID:3199-1676376000-1676379600@www.ctnnortheastnode.org
SUMMARY:Screening for Substance Use in Primary Care: Screening Tools and Guidance for Implementation
DESCRIPTION:Presenter: Jennifer McNeely\, MD \nSponsor: American Psychiatric Association (APA) and American Academy of Addiction Psychiatry (AAAP) \nCost: No Fee \nTarget audience: Physicians\, psychologists\, social workers\, physician assistants\, pharmacists\, interprofessional team\, residents/fellows\, medical students\, other mental health clinicians \nCredit Designations Available: AMA PRA Category 1 Credit™\, AAPA Category 1 CME\, Social Work CE Credit\, Nursing Contact Hours\, Pharmacy CE Credit\, Interprofessional Continuing Education (IPCE) Credit \nAbout the webinar: Substance use drives poor health outcomes in the general population. SUD continues to lead to more death and disability than any other preventable condition\, with alcohol being the third leading cause of preventable death in the United States. Drug-related overdoses also continue to climb with > 108\,000 overdose deaths per year as well as the leading all-cause mortality under the age of 50. Primary care is generally not thought of as a place to access mental health care\, but it may be a critical tool in noticing substance use behaviors and proactively loop patients into needed care. This webinar aims to introduce screening tools that can be administered during primary care visits. \nEducational objectives:  At the conclusion of this activity participants should be able to: \n\nApply the screening guidelines and current state of the evidence to your practice.\nReview and evaluate screening instruments introduced in the webinar.\nConsider screening implementation in general medical settings based on the needs of your current patients.\n\nRegister Now
URL:https://www.ctnnortheastnode.org/event/screening-for-substance-use-in-primary-care-screening-tools-and-guidance-for-implementation/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230222T120000
DTEND;TZID=America/New_York:20230222T130000
DTSTAMP:20260405T162649
CREATED:20230209T142208Z
LAST-MODIFIED:20230209T142208Z
UID:3198-1677067200-1677070800@www.ctnnortheastnode.org
SUMMARY:Illicit Drug Supply: Fentanyl and Xylazine
DESCRIPTION:Presenter: Richard Dawson\, PhD\, Research Professor at the Vermont Center for Behavior and Health at UVM and a Professor Emeritus at the UCLA Department of Psychiatry \nThis presentation will explore current information about fentanyl and xylazine including: drug supply information\, pharmacology\, clinical effects\, medical impacts\, harm reduction and treatment information. Considerations for rural populations will be discussed. \nRegister now! \n 
URL:https://www.ctnnortheastnode.org/event/illicit-drug-supply-fentanyl-and-xylazine/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230307T120000
DTEND;TZID=America/New_York:20230307T130000
DTSTAMP:20260405T162649
CREATED:20230307T121503Z
LAST-MODIFIED:20230307T121503Z
UID:3207-1678190400-1678194000@www.ctnnortheastnode.org
SUMMARY:Substance Use Disorders in Late Life
DESCRIPTION:Register Now \n  \nPresenters: Roberto D. Sanchez\, DO and Ali Abbas Asghar-Ali\, MD \nTarget Audience: This activity is designed for Psychiatrists\, Physicians\, Physician Assistants\, Nurses/Nurse Practitioners\, Social Workers\, Psychologists\, Pharmacists\, other mental health clinicians working within addiction. This activity is accredited for Physicians\, Physician Assistants\, Social Workers\, Pharmacists\, and Healthcare teams. \nCredit Designations Available: AMA PRA Category 1 Credit™\, AAPA Category 1 CME\, Social Work CE Credit\, Pharmacy CE Credit\, Interprofessional Continuing Education (IPCE) Credit \nWebinar Description: The number of older adults is projected to exceed 72.1 million people by 2030 and members of the baby boomer generation have the highest rates of early life substance use which increases likelihood of substance use in later life. With rates of SUDs growing in older individuals\, this population is experiencing mood and anxiety disorders\, sleep disorders\, cognitive impairments\, sleep disruption\, hepatic complications\, and greater physical disability as co-morbid symptoms of substance use and aging. This webinar aims to improve awareness of the occurrence and impact of SUD as well as teach geriatric SUD screening tools. Finally\, the webinar will offer recommendations for pharmacologic and psychosocial treatments for SUD in older adults. \nEducational Objectives: \n\nGain awareness of the occurrence and impact of substance use disorders (SUDs) in late-life.\nEmploy appropriate screening tools to identify SUD in late-life.\nIdentify how SUDs in late-life differ from SUDs in younger adults.\nAdapt pharmacologic treatments for older adults with SUD.\nImplement recommendations for psychosocial treatments for the treatment of SUD.\n\nRegister Now
URL:https://www.ctnnortheastnode.org/event/substance-use-disorders-in-late-life/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230309T130000
DTEND;TZID=America/New_York:20230309T140000
DTSTAMP:20260405T162649
CREATED:20230306T215025Z
LAST-MODIFIED:20230306T215025Z
UID:3206-1678366800-1678370400@www.ctnnortheastnode.org
SUMMARY:How Adding a Clinical Pharmacist Improves Access to Addiction Care
DESCRIPTION:Register here \nPresenters: \nBen Miskle\, PharmD\, University of Iowa Hospitals and Clinics \nAlison Lynch\, MD\, MS\, University of Iowa Hospitals and Clinics \nSponsor: American Academy of Addiction Psychiatry (AAAP) \nCost: No Fee \nTarget audience: Physicians\, nurse practitioners or other advanced practice nurses\, PAs\, social workers\, and pharmacists \nCredit designations available: Pharmacy CE Credit\, AMA PRA Category 1 Credit™\, AAPA Category 1 CME\, Nursing Contact Hours \, Social Work CE Credit\, Interprofessional Continuing Education (IPCE) Credit \nAbout the webinar: There is a shortage of psychiatrists to meet the mental health needs of patients in the United States\, and this shortage was exacerbated by the COVID-19 pandemic. The incidence of substance use disorders (SUD) increased significantly during the pandemic and there is an insufficient number of physicians trained to meet patient needs. This gap creates problems across the healthcare system for providers\, patients and caregivers. One solution to this problem is integrating other members of the healthcare team to expand access to mental health and substance use treatments. Clinical pharmacists have extensive knowledge on pharmacologic treatment of SUD and are often underutilized resources. This presentation will highlight a successful model of how healthcare professionals can work together to coordinate and optimize care of patients living with SUD. The role of the psychiatric pharmacist as a partner in SUD care in different treatment settings will be explored and discussed. \nEducational objectives:  At the conclusion of this activity participants should be able to: \n\nDescribe how health care professionals can successfully work together to coordinate and optimize care of patients with substance use disorders (SUD).\nExamine the role of the pharmacist as a member of the interprofessional SUD team and the impact on patient care outcomes.\nIdentify SUD treatment settings where pharmacists can be integrated and the enhanced services that can be provided.\n\nRegister here
URL:https://www.ctnnortheastnode.org/event/how-adding-a-clinical-pharmacist-improves-access-to-addiction-care/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230317T120000
DTEND;TZID=America/New_York:20230317T130000
DTSTAMP:20260405T162649
CREATED:20230310T124420Z
LAST-MODIFIED:20230310T124420Z
UID:3208-1679054400-1679058000@www.ctnnortheastnode.org
SUMMARY:Nurses’ Practices with People Experiencing Opioid Use Disorder
DESCRIPTION:Register Now \n  \nPresenter: Timothy J. Sowicz\, PhD\, RN \nCost: No Fee \nTarget audience: This activity is designed for for Nurses\, MAT Team Providers\, Addictions Specialists\, SUD Project Directors\, Managers\, and Facilitators. This activity is accredited for nurses. \nCredit Designations Available: Nursing CE \nWebinar description: The purpose of this presentation is to present the findings from a narrative literature review that was conducted to understand nurses’ practices with persons with opioid use disorder (OUD). Nurses are a sizable portion of the healthcare workforce; therefore\, understanding their unique\, disciplinary contributions for people with OUD is important. Twenty-one studies were included in the review and most were non-experimental and conducted in Europe and North America. Nurses’ practices were described with various levels of specificity but aligned well with the scopes of practice of the American Nurses Society and the International Nurses Society on Addictions. \nEducational objectives:  At the conclusion of this activity participants should be able to: \n\nDiscuss the methods used for conducting this synthesis research.\nAnalyze professional scope of practice standards for nurses’ work with people with opioid use disorder\nSummarize at least two findings from the review\n\nRegister Now
URL:https://www.ctnnortheastnode.org/event/nurses-practices-with-people-experiencing-opioid-use-disorder/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230321T140000
DTEND;TZID=America/New_York:20230321T150000
DTSTAMP:20260405T162649
CREATED:20230317T205952Z
LAST-MODIFIED:20230317T205952Z
UID:3212-1679407200-1679410800@www.ctnnortheastnode.org
SUMMARY:Co-occurring Opioid and Stimulant Use Disorders: Treatment and Management Approaches
DESCRIPTION:Register Now \nPresenters: Jonathan Craig Allen\, MD\, FASAM\, and Marc Fishman\, MD \nSponsor: National Council for Mental Wellbeing–NCMW \nContinuing education information: AMA PRA Category 1 Credit™\, Nursing Contact Hours\, AAPA Category 1 CME credit\, SW CE credit\, Pharmacy CE credit and IPCE credit \nTarget Audience: This activity is designed for physicians\, nurses\, PAs\, pharmacists\, social workers\, peer recovery support specialists\, psychologists\, other behavioral health providers. This activity is accredited for physicians\, nurses\, PAs\, pharmacists\, social workers\, interprofessional teams and other health professionals. \nAbout the webinar: Research indicates a lack of training and programming specific to treating and managing co-occurring opioid and stimulant use disorders\, despite the increased risk of overdose bolstered by the ever-changing and adulterated drug supply. While MOUD is the gold standard of care for treating OUD\, there are no FDA-approved medications for treating stimulant use disorder\, though behavioral therapies like contingency management have been well studied. These challenges highlight the need to identify promising treatment strategies to ensure individuals with co-occurring opioid and stimulant use disorders are effectively engaged in care to prevent overdose. This session will equip BH providers and organizations in this space\, including Community Behavioral Health Clinics (CCBHCs)\, with the tools necessary to effectively engage and provide quality\, team-based care and services to individuals with co-occurring opioid and stimulant use disorders in order to improve health outcomes\, reduce overdose risk\, and support long-term recovery. \nEducational objectives: \n\nDescribe the broad context of co-occurring opioid and stimulant use and overdose risk in the U.S.\nReview evidence-based strategies for treating opioid use disorders and promising practices for stimulant use\nIdentify evidence-based and promising strategies for treating co-occurring opioid and stimulant use disorders\nReview psychiatric co-morbidities associated with opioid and stimulant use disorders\n\nRegister Now
URL:https://www.ctnnortheastnode.org/event/co-occurring-opioid-and-stimulant-use-disorders-treatment-and-management-approaches/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230329T120000
DTEND;TZID=America/New_York:20230329T130000
DTSTAMP:20260405T162649
CREATED:20230315T133137Z
LAST-MODIFIED:20230315T133137Z
UID:3210-1680091200-1680094800@www.ctnnortheastnode.org
SUMMARY:Three years of the COVID-19 Pandemic: What we've learned\, and how it can make us better at treating rural patients with SUD
DESCRIPTION:This presentation will explore lessons learned from the COVID-19 pandemic as they relate to rural populations with substance use disorder. Register and attend to learn more! \nSpeaker:\nSarah Jacobs\, MD\, MEd\, Oculofacial Reconstructive Surgeon with the University of Alabama at Birmingham and the Science Writer for UVM CORA \nRegister Now
URL:https://www.ctnnortheastnode.org/event/three-years-of-the-covid-19-pandemic-what-weve-learned-and-how-it-can-make-us-better-at-treating-rural-patients-with-sud/
CATEGORIES:Other Related
ORGANIZER;CN="UVM Center on Rural Addiction":MAILTO:CORA@uvm.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230405T120000
DTEND;TZID=America/New_York:20230405T133000
DTSTAMP:20260405T162649
CREATED:20230329T190608Z
LAST-MODIFIED:20230329T190608Z
UID:3215-1680696000-1680701400@www.ctnnortheastnode.org
SUMMARY:Treatment Considerations in the Age of Fentanyl
DESCRIPTION:Fentanyl and other high-potency synthetic opioids are increasingly present in the U.S. drug supply. Healthcare systems\, treatment providers\, and justice systems are grappling with the physiological consequences of chronic fentanyl use and how its use may impact treatment. \nSpeakers: – Kathryn Cates-Wessel\, CEO\, American Academy of Addiction Psychiatry – John J. Mariani\, MD\, Associate Professor of Clinical Psychiatry Division on Substance Use Disorders\, Columbia University – Tisha Wiley\, PhD\, Branch Chief\, Associate Director for Justice Systems\, NIDA – Jessica Hulsey\, Executive Director\, Addiction Policy Forum. \nPresenters will discuss practical clinical practice-based guidance on treating opioid use disorder in the age of fentanyl\, the use of medications for opioid use disorder (MOUD) in the treatment of individuals using fentanyl\, and other considerations and challenges. This free webinar is sponsored by the Addiction Policy Forum\, the Justice Community Opioid Innovation Network (JCOIN) at the National Institute on Drug Abuse (NIDA)\, the American Academy of Addiction Psychiatry (AAAP)\, and the Providers Clinical Support System (PCSS). \n This webinar is part of the JCOIN Speaker Series. Led by the National Institute on Drug Abuse (NIDA) and funded by the NIH HEAL Initiative®\, JCOIN is a groundbreaking initiative designed to advance scientific knowledge on effective policies\, practices\, and interventions to address the opioid crisis among justice-involved individuals\, by partnering researchers with justice agencies and community health programs. \nRSVP
URL:https://www.ctnnortheastnode.org/event/treatment-considerations-in-the-age-of-fentanyl/
CATEGORIES:Other Related
ORGANIZER;CN="Addiction Policy Forum":MAILTO:info@addictionpolicy.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230406T150000
DTEND;TZID=America/New_York:20230406T160000
DTSTAMP:20260405T162649
CREATED:20230403T224440Z
LAST-MODIFIED:20230403T224440Z
UID:3218-1680793200-1680796800@www.ctnnortheastnode.org
SUMMARY:Mindfulness-Oriented Recovery Enhancement: Clinical Outcomes and Biobehavioral Mechanisms of an Evidence-Based Therapy for Chronic Pain\, Opioid Misuse\, and Opioid Use Disorder
DESCRIPTION:Register Now \n  \nPresenter: Eric Garland\, PhD\, LCSW \nSponsoring organization: American Society for Pain Management Nursing (ASPMN) \nTarget audience: Clinical providers including Physicians\, PAs and NPs \nAbout the webinar: Half of all people with a substance use disorder (SUD) have chronic pain\, and more than a third have a co-occurring psychiatric disorder. The ongoing opioid crisis is a case in point\, where physical and emotional pain fuel opioid addiction and continue to drive countless deaths of despair to this day. Unfortunately\, there are few evidence-based therapies that can simultaneously treat this complex comorbidity. To meet this need\, Mindfulness-Oriented Recovery Enhancement (MORE) was generated through a decade-long treatment development process funded by the National Institutes of Health. Rooted in affective neuroscience\, MORE unites mindfulness training\, cognitive-behavioral therapy\, and principles from positive psychology into an integrative therapy designed to target addiction\, stress\, and pain. This session will detail the theory underlying MORE\, research data demonstrating MORE’s effectiveness\, and unique clinical skills integral to this novel treatment. MORE has been tested in 11 clinical trials funded by more than $40 million in federal research grants. In the largest trial of MORE (250 patients with opioid misuse/OUD)\, MORE decreased opioid misuse by 45% by 9-month follow-up\, more than doubling the effect of standard therapy. MORE also significantly decreased chronic pain\, distress\, depression\, and PTSD. In addition\, MORE has been shown to improve outcomes among people receiving medication assisted treatment. Neuroscience shows that MORE decreases the extent to which the brain is triggered by drug cues\, while increasing brain responses to natural\, healthy rewards. MORE is now being disseminated across the U.S. This dissemination effort is urgently needed\, in light of the opioid settlement monies that are now reaching the states to help alleviate the opioid crisis. \nEducational objectives: \n\nIdentify three cognitive\, affective\, and neurobiological mechanisms implicated in substance use disorders\, affective disorders\, and chronic pain.\nExplain three therapeutic techniques to reduce craving\, regulate addictive behavior\, decrease negative emotions\, and/or manage chronic pain.\nDescribe the clinical outcomes of MORE for chronic pain and opioid misuse.\n\nCredit education information: The Greater Kansas City Chapter of the American Society for Pain Management Nursing® is approved as a provider of continuing nursing education by the Kansas State Board of Nursing. This course offering has been submitted for approval for nursing contact hours applicable for RN\, LPN and LMHT relicensure.
URL:https://www.ctnnortheastnode.org/event/mindfulness-oriented-recovery-enhancement-clinical-outcomes-and-biobehavioral-mechanisms-of-an-evidence-based-therapy-for-chronic-pain-opioid-misuse-and-opioid-use-disorder/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230407T120000
DTEND;TZID=America/New_York:20230407T130000
DTSTAMP:20260405T162649
CREATED:20230317T202141Z
LAST-MODIFIED:20230317T202141Z
UID:3211-1680868800-1680872400@www.ctnnortheastnode.org
SUMMARY:Initiating Buprenorphine for Patients Using Fentanyl
DESCRIPTION:Register Now \nPresenter: Brian Hurley\, MD\, MBA\, DFASAM\, FAPA \nCost: No Fee \nTarget audience: Nurses\, Addictions Specialists\, SUD Project Directors\, Managers\, and Facilitators and MOUD (medications for opioid use disorder) providers \nCredit Designations Available: Nursing CE \nWebinar description: This webinar will review variations on buprenorphine dosing that can be considered for patients with opioid use disorder involving fentanyl. The presenters will review the evidence for and describe low dose buprenorphine initiation of protocols\, high dose buprenorphine initiation of protocols\, approaches to help support patients stop using full agonist opioids for a longer period of time\, and a clinical approach to referring patients to alternative medications for opioid use disorder. \nEducational objectives:  At the conclusion of this activity participants should be able to: \n\nCompare and contrast low-dose\, high-dose\, standard dose\, and variations for the timing and setting for initiating buprenorphine to treat opioid use disorder involving fentanyl.\nDesign a treatment plan that factors in the risks and benefits of buprenorphine to treat opioid use disorder in consideration of the set\, setting\, and patient’s priorities for their opioid use disorder treatment.\nRecognize the limitations of buprenorphine treatment of opioid use disorder and how to refer to alternative treatments.\n\nRegister Now
URL:https://www.ctnnortheastnode.org/event/initiating-buprenorphine-for-patients-using-fentanyl/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230411T150000
DTEND;TZID=America/New_York:20230411T160000
DTSTAMP:20260405T162649
CREATED:20230329T185843Z
LAST-MODIFIED:20230329T185843Z
UID:3214-1681225200-1681228800@www.ctnnortheastnode.org
SUMMARY:Xylazine and How it Harms People Who Use Drugs
DESCRIPTION:Register now! \nPresenters: Raagini Jawa\, MD \nCost: No fee \nTarget Audience: This activity was developed to meet the needs of physicians and all interprofessional healthcare providers. \nDescription: We will review what is known to date on Xylazine\, a CNS depressant\, which has been linked to an increasing number of overdose deaths in the US. This Roundtable will discuss its physiologic effects\, and risk of xylazine harms including overdose and wounds along with suggested clinical best practices for providers and patients. \nThis talk discusses substance use disorder treatment in a post-COVID world. \nDiscussion is designed to promote interactivity through an informal “round table” conversation. Attendees will be given the opportunity to speak directly with the presenter to ask questions and discuss issues. \nNOTE: To encourage participants to speak freely\, recordings of these roundtables are not available. \nRegister now!
URL:https://www.ctnnortheastnode.org/event/xylazine-and-how-it-harms-people-who-use-drugs/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230419T150000
DTEND;TZID=America/New_York:20230419T160000
DTSTAMP:20260405T162649
CREATED:20230412T162432Z
LAST-MODIFIED:20230412T162432Z
UID:3219-1681916400-1681920000@www.ctnnortheastnode.org
SUMMARY:Opioid Use Disorder and Social Determinants of Health
DESCRIPTION:Presenters: \n  \n\nRachel Talley\, MD\, Assistant Professor of Clinical Psychiatry/Director\, Fellowship in Public and Community Psychiatry\n\n\nJessica Isom\, MD\, Attending Psychiatrist\, Codman Square Health Center/Clinical Instructor\, Yale University/Faculty Lead\, Social Justice and Health Equity Curriculum\n\nSponsor: National Council for Mental Wellbeing–NCMW \nContinuing education information: Council for Mental Wellbeing will not be providing Continuing Medical Education for this event. \nTarget Audience: Interprofessional teams\, family/patients\, nurses\, physicians\, psychiatrists\, psychologists\, social workers\, students/educators \nAbout the webinar: The opioid crisis continues to have a devastating impact on families and communities across the United States. Individuals from marginalized communities\, including Black\, Indigenous and People of Color (BIPOC) communities and individuals who are uninsured or have lower incomes with opioid use disorders (OUD) often experience challenges accessing and sustaining treatment services. Many of these challenges stem from unaddressed social determinants of health factors (housing\, education\, geography etc.) as well as systemic inequities across all care settings. Lack of attention to these factors can lead to inadequate care for OUD and inadequate support for long-term recovery.we will discuss factors that facilitate and hinder engagement in long-term OUD treatment and recovery for BIPOC individuals\, as well as identify strategies for organizations to assess and effectively address opioid use among BIPOC individuals through addressing social determinants of health. \nEducational objectives: \n\nExamine how social determinants of health may impact initiation of and ongoing substance use\nDiscuss factors that facilitate and hinder engagement in long-term treatment and recovery for BIPOC individuals\nIdentify strategies for organizations to assess and address opioid use among BIPOC individuals through addressing social determinants of health\n\nRegister Now
URL:https://www.ctnnortheastnode.org/event/opioid-use-disorder-and-social-determinants-of-health/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230517T120000
DTEND;TZID=America/New_York:20230517T130000
DTSTAMP:20260405T162649
CREATED:20230504T205606Z
LAST-MODIFIED:20230504T205606Z
UID:3223-1684324800-1684328400@www.ctnnortheastnode.org
SUMMARY:Changing the Default: Moving to an Opt-Out Approach for Treating Tobacco Use Disorders
DESCRIPTION:Join us on Wednesday\, May 17th for the #VCBHLectureSeries as we welcome Kimber Richter\, PhD\, MPH\, Professor of Population Health at the University of Kansas Medical Center. Dr. Richter will present “Changing the Default: Moving to an Opt-Out Approach for Treating Tobacco Use Disorders.” \nDr. Richter received her Master of Public Health from the University of Kansas Medical School and her PhD in Behavioral Psychology from the University of Kansas Department of Human Development and Family Life\, now known as the Department of Applied Behavioral Sciences. She directs a hospital-based smoking cessation service\, UKanQuit\, that serves over 2\,000 smokers per year. Her professional service includes being a member of editorial boards and serving on a number of NIH and other grant review panels. \n\n\n\nRemote Registration
URL:https://www.ctnnortheastnode.org/event/changing-the-default-moving-to-an-opt-out-approach-for-treating-tobacco-use-disorders/
CATEGORIES:Other Related
ORGANIZER;CN="UVM Vermont Center on Behavior and Health":MAILTO:Nicole.Twohig@uvm.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230522T170000
DTEND;TZID=America/New_York:20230522T190000
DTSTAMP:20260405T162649
CREATED:20230515T190957Z
LAST-MODIFIED:20230515T190957Z
UID:3232-1684774800-1684782000@www.ctnnortheastnode.org
SUMMARY:Drug Use in Pregnancy (ASAM FAME Session 7)
DESCRIPTION:Register Now \nQuestions about registering should be directed to: ASAM Education by email ateducation@asam.org \nPresenters: \n\nAbby Letcher\, MD\, FASAM\nAngela Colistra\, PhD\, LPC\, CAADC\, CCS\nShanna Diaz\, DO\nLeslie Hayes\, MD\n\nSeries: This 2-hour\, virtual-live session is part of the FAME 8-session series and will cover overdose prevention and harm reduction. The FAME series is a facilitated\, in-depth discussion of real patient cases provided by participants with the opportunity to receive mentoring and feedback from multi-disciplinary addiction expert faculty. The series is designed for members of the healthcare team who are new to treating patients with addiction so they can gain additional insights\, knowledge\, and confidence. \nSponsor: American Society of Addiction Medicine (ASAM) \nCost: No Fee \nNOTE: This webinar will not be archived for on-demand viewing. \nEach two-hour virtual FAME session includes: \n\nOne 20-to-30-minute didactic presentation on a featured addiction-related topic\nTwo 40-minute case reviews with a panel of multi-disciplinary addiction experts\nUp to (2) CME/CE credits per session\n\nTarget Audience: The target audience for this introductory level activity includes: physicians\, PAs\, nurses\, nurse practitioners\, social workers\, psychologists\, counselors\, addiction educators\, and other clinicians part of the care team. \n  \nRegister Now
URL:https://www.ctnnortheastnode.org/event/drug-use-in-pregnancy-asam-fame-session-7/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230531T120000
DTEND;TZID=America/New_York:20230531T130000
DTSTAMP:20260405T162649
CREATED:20230517T200443Z
LAST-MODIFIED:20230517T200443Z
UID:3233-1685534400-1685538000@www.ctnnortheastnode.org
SUMMARY:Nurse Practitioners and Physician Assistants as Buprenorphine Providers: Facilitators and Barriers
DESCRIPTION:This presentation will describe the expansion of nurse practitioners and other advanced practice clinicians into opioid use disorder treatment\, particularly in rural communities. It will also explore barriers and facilitators regarding nurse practitioner engagement in buprenorphine treatment\, including regulations\, education\, and broader social factors such as stigma. Specific considerations for advanced practice clinicians’ work with members of rural communities will be discussed. Register and attend to learn more! \nSpeakers:\nJoanne Spetz\, PhD\, Director and Brenda and Jeffrey L. Kang Presidential Chair in Health Care Financing at the Philip R. Lee Institute for Health Policy Studies (IHPS)\, University of California San Francisco \nJackie Bray\, DNP; FNP-C\, Family Nurse Practitioner and buprenorphine prescriber\, Howard Center in Vermont \n  \nRegister Now \n  \n  \n 
URL:https://www.ctnnortheastnode.org/event/nurse-practitioners-and-physician-assistants-as-buprenorphine-providers-facilitators-and-barriers/
CATEGORIES:Other Related
ORGANIZER;CN="UVM Center on Rural Addiction":MAILTO:CORA@uvm.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230531T150000
DTEND;TZID=America/New_York:20230531T160000
DTSTAMP:20260405T162649
CREATED:20230523T173809Z
LAST-MODIFIED:20230523T173809Z
UID:3234-1685545200-1685548800@www.ctnnortheastnode.org
SUMMARY:Opioid Use Disorder in Pregnant and Postpartum People: The Treatment and Policy Landscape
DESCRIPTION:Register Now \nPresenters: Maria Manriquez\, MD\, FACOG\, FASAM\, PMH-C; Tara Sundem\, APRN\, NNP-BC; and Tawni Carson \nSponsor: National Council for Mental Wellbeing–NCMW \nNOTE: The National Council for Mental Wellbeing will not be providing Continuing Medical Education for this event. \nTarget Audience: This activity is designed for interprofessional teams\, families and patients\, students and educators\, nurses\, physicians\, psychiatrists\, psychologists and social workers. \nAbout the webinar: Opioid use disorder (OUD) can be a fatal addiction with complex implications for new and/or expecting mothers. OUD challenges can lead to many complications for mother and child\, including low birth weight\, clinical challenges with medical dosing and increased risk of accidental death. In the U.S. alone\, a baby is born passively dependent every 15 minutes. To ensure best health outcomes for both mother and child\, policies must allow engagement in evidence-based treatment and protect clients from legal ramifications. Hear from a physician\, clinic director and an individual with lived experience to broaden understandings about the treatment and policy landscape for pregnant and postpartum women with OUD. \nEducational objectives: \n\nReview the current landscape of opioid use disorder treatment for pregnant and postpartum women in the U.S.\nDescribe the neurobiology of opioid use disorder among pregnant and postpartum women\nExamine legal challenges related to pregnant women and mothers with substance use disorders\nDiscuss recent policy changes that impact how opioid use disorder treatment is provided\n\nRegister Now
URL:https://www.ctnnortheastnode.org/event/opioid-use-disorder-in-pregnant-and-postpartum-people-the-treatment-and-policy-landscape/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230628T120000
DTEND;TZID=America/New_York:20230628T130000
DTSTAMP:20260405T162649
CREATED:20230614T160658Z
LAST-MODIFIED:20230614T160658Z
UID:3247-1687953600-1687957200@www.ctnnortheastnode.org
SUMMARY:Expanding Harm Reduction Access in the US for Rural and Other Underserved Populations
DESCRIPTION:This presentation will describe research around syringe service programs and methods of harm reduction distribution. Specific considerations for reaching members of rural communities will be discussed. \nLearning objectives: \n1. Discuss the need for novel approaches for distributing harm reduction supplies \n2. Describe benefits and challenges regarding syringe service programs \n3. Outline specifics of programs that mail out harm reduction supplies\, including naloxone \n4. Discuss the impact of such programs on members of rural and other underserved populations \nSpeaker:\nCzarina Behrends\, PhD\, MPH\, Assistant Professor of Population Health Studies\, Weill Cornell Medical College \nRegister Now \n 
URL:https://www.ctnnortheastnode.org/event/expanding-harm-reduction-access-in-the-us-for-rural-and-other-underserved-populations/
CATEGORIES:Other Related
ORGANIZER;CN="UVM Center on Rural Addiction":MAILTO:CORA@uvm.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230726T120000
DTEND;TZID=America/New_York:20230726T130000
DTSTAMP:20260405T162649
CREATED:20230717T143550Z
LAST-MODIFIED:20230717T143550Z
UID:3248-1690372800-1690376400@www.ctnnortheastnode.org
SUMMARY:A Qualitative Analysis of US State Laws Regulating Incentives for Health Behavior
DESCRIPTION:This presentation will describe the results of a qualitative study examining state laws regulating incentives for health behavior. Such laws may have important implications for provision of contingency management for substance use disorder\, including in rural areas. Register and attend to learn more! \nSpeaker:\nBarbara “Basia” Andraka-Christou\, PhD\, JD\, Assistant Professor in the School of Global Health Management and Informatics\, and the College of Medicine at UCF \nRegister Now
URL:https://www.ctnnortheastnode.org/event/a-qualitative-analysis-of-us-state-laws-regulating-incentives-for-health-behavior/
CATEGORIES:Other Related
ORGANIZER;CN="UVM Center on Rural Addiction":MAILTO:CORA@uvm.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230726T150000
DTEND;TZID=America/New_York:20230726T160000
DTSTAMP:20260405T162649
CREATED:20230719T155430Z
LAST-MODIFIED:20230719T155430Z
UID:3249-1690383600-1690387200@www.ctnnortheastnode.org
SUMMARY:Providing Comprehensive Care in Opioid Treatment Program: A Policy and Provider Perspective
DESCRIPTION:Presenters: \n\nMark Parrino\, President and CEO of The American Association for the Treatment of Opioid Dependence\, Inc.\nJennifer Seib\, VP of Strategic Initiatives and Integration at BestSelf Behavioral Health\n\nSponsor: National Council for Mental Wellbeing–NCMW \nCredit designational available: None \nTarget Audience: Interprofessional teams\, patients\, educators\, nurses\, physicians\, psychiatrists\, psychologists\, executives\, clinical staff\, administrators and social workers. \nAbout the webinar: The current opioid and drug overdose crisis continues to have a devastating impact on morbidity and mortality in the United States. With the rise in use of potent synthetic opioids like fentanyl in the drug supply\, creating linkages to comprehensive substance use related services is critical. Opioid Treatment Programs (OTP) and the comprehensive care and services they provide play a vital role in addressing this need\, yet challenges remain. Despite clear evidence of the benefits of OTP’s\, access to OTPs in some parts of the country is limited; stigma related to the use of methadone remains a challenge. Yet in the face of these headwinds\, many OTPs are providing comprehensive leading-edge services to address the opioid and drug overdose crisis. \nEducational objectives: \n\nExamine current policy landscape for OTP’s.\nDiscuss the value proposition of becoming and OTP.\nIdentify strategies to provide comprehensive services in an OTP.\nDescribe what services can be offered at an OTP.\n\nRegister Now
URL:https://www.ctnnortheastnode.org/event/providing-comprehensive-care-in-opioid-treatment-program-a-policy-and-provider-perspective/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230823T120000
DTEND;TZID=America/New_York:20230823T130000
DTSTAMP:20260405T162649
CREATED:20230816T133507Z
LAST-MODIFIED:20230816T133507Z
UID:3262-1692792000-1692795600@www.ctnnortheastnode.org
SUMMARY:Buprenorphine in the Age of Fentanyl: Discussing the New Guidance
DESCRIPTION:Presenter: John Mariani\, MD \nTarget Audience: This activity was developed to meet the needs of physicians and interprofessional healthcare providers. \nDiscussion is designed to promote interactivity through an informal “round table” conversation. Attendees will be given the opportunity to speak directly with the presenter to ask questions and discuss issues. \nRegister now
URL:https://www.ctnnortheastnode.org/event/buprenorphine-in-the-age-of-fentanyl-discussing-the-new-guidance/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230830T120000
DTEND;TZID=America/New_York:20230830T130000
DTSTAMP:20260405T162649
CREATED:20230816T133229Z
LAST-MODIFIED:20230816T133229Z
UID:3261-1693396800-1693400400@www.ctnnortheastnode.org
SUMMARY:Reaching People Where They're At: Smoking Cessation Treatment Delivery at Your Door
DESCRIPTION:This presentation will discuss novel ways to deliver evidence-based treatment for smoking cessation within and across rural areas. It will focus on 4 separate clinical trials of medication sampling\, each demonstrating feasibility and efficacy of a simple yet novel treatment approach to reach a broad spectrum of smokers\, including those who may not yet want to quit. Register and attend to learn more! \nSpeaker:\nMatthew Carpenter\, PhD\, Professor in the Department of Psychiatry & Behavioral Sciences and co-leader for the Cancer Control Program at the Hollings Cancer Center of the Medical University of South Carolina \nRegister Now
URL:https://www.ctnnortheastnode.org/event/reaching-people-where-theyre-at-smoking-cessation-treatment-delivery-at-your-door/
CATEGORIES:Other Related
ORGANIZER;CN="UVM Center on Rural Addiction":MAILTO:CORA@uvm.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230908T120000
DTEND;TZID=America/New_York:20230908T130000
DTSTAMP:20260405T162649
CREATED:20230905T194709Z
LAST-MODIFIED:20230905T194709Z
UID:3269-1694174400-1694178000@www.ctnnortheastnode.org
SUMMARY:Clinical Primer and Discussion on Weekly and Monthly Injectable Buprenorphine
DESCRIPTION:Presenter: Michelle Lofwall\, MD \nTarget Audience: This activity was developed to meet the needs of physicians and interprofessional healthcare providers. \nDiscussion is designed to promote interactivity through an informal “round table” conversation. Attendees will be given the opportunity to speak directly with the presenter to ask questions and discuss issues. \nRegister now
URL:https://www.ctnnortheastnode.org/event/clinical-primer-and-discussion-on-weekly-and-monthly-injectable-buprenorphine/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230926T140000
DTEND;TZID=America/New_York:20230926T150000
DTSTAMP:20260405T162649
CREATED:20230919T155800Z
LAST-MODIFIED:20230919T155800Z
UID:3270-1695736800-1695740400@www.ctnnortheastnode.org
SUMMARY:Buprenorphine Dosing and Preparations in the Era of Fentanyl
DESCRIPTION:Presenters: \nGail D’Onofrio\, MD and Andrew Herring\, MD \nTarget Audience: This activity was developed to meet the needs of physicians and interprofessional healthcare providers. \nDiscussion is designed to promote interactivity through an informal “round table” conversation. Attendees will be given the opportunity to speak directly with the presenter to ask questions and discuss issues. \nRegister now
URL:https://www.ctnnortheastnode.org/event/buprenorphine-dosing-and-preparations-in-the-era-of-fentanyl/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230929T080000
DTEND;TZID=America/New_York:20230929T163000
DTSTAMP:20260405T162649
CREATED:20230822T162645Z
LAST-MODIFIED:20230822T162901Z
UID:3264-1695974400-1696005000@www.ctnnortheastnode.org
SUMMARY:Addressing the Intersection of Pain Management and Opioid Use: Integrating Care to Promote Healthy Outcomes
DESCRIPTION:This hybrid full-day training summit will explore the clinical intersection of pain and opioid use. Interdisciplinary attendees will learn about evidence-based practices (pharmacological and non) for treating these complex and often co-occurring conditions. More information \nIn-person participation is preferred\, though a virtual option is also available. This Summit will focus on addressing pain and opioid use from a team-based approach; as such\, virtual attendees may not get the same experience as those who attend in-person.\n\nRegister Now
URL:https://www.ctnnortheastnode.org/event/addressing-the-intersection-of-pain-management-and-opioid-use-integrating-care-to-promote-healthy-outcomes/
CATEGORIES:Northeast Node
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231018T130000
DTEND;TZID=America/New_York:20231018T140000
DTSTAMP:20260405T162649
CREATED:20231011T144032Z
LAST-MODIFIED:20231011T144032Z
UID:3282-1697634000-1697637600@www.ctnnortheastnode.org
SUMMARY:Ready or Not Here Come the Nitazenes
DESCRIPTION:Presenter: Edwin Salsitz\, MD \nTarget Audience: This activity was developed to meet the needs of physicians and interprofessional healthcare providers. \nDiscussion is designed to promote interactivity through an informal “round table” conversation. Attendees will be given the opportunity to speak directly with the presenter to ask questions and discuss issues. \nRegister now
URL:https://www.ctnnortheastnode.org/event/ready-or-not-here-come-the-nitazenes/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231115T120000
DTEND;TZID=America/New_York:20231115T130000
DTSTAMP:20260405T162649
CREATED:20231110T190402Z
LAST-MODIFIED:20231110T190402Z
UID:3304-1700049600-1700053200@www.ctnnortheastnode.org
SUMMARY:Women & Alcohol: What does stress have to do with it?
DESCRIPTION:Join us on Wednesday\, November 15th for the #VCBHLectureSeries as we welcome Sherry McKee\, PhD\, Director\, Yale Behavioral Pharmacology Laboratory. Dr. McKee will present “Women & Alcohol: What does stress have to do with it?” \nDr. McKee directs a translational program of research focused on treatment development for addictive disorders\, with an emphasis on women and more recently criminal justice populations. Her work spans clinical trials\, behavioral pharmacology\, survey research\, and epidemiological research to uncover mechanisms underlying poor outcomes and to translate these finding into improved interventions. She also leads a federally funded partnership between Yale University\, the of Connecticut Department of Mental Health and Addiction Services\, and the State of Connecticut Department of Correction\, to develop and implement an integrated system of addiction care for adults returning to their communities following incarceration. \nThe VCBH Monthly Lecture Series was originally created as an in-person series designed as a way to interact and engage with top researchers in the intersectional fields we often work with at VCBH including behavior change\, addiction\, chronic disease\, and health disparities for people who are at increased risk. Following the COVID-19 pandemic\, the VCBH made remote viewing available for the lecture series. \nRemote Registration
URL:https://www.ctnnortheastnode.org/event/women-alcohol-what-does-stress-have-to-do-with-it/
CATEGORIES:Other Related
ORGANIZER;CN="UVM Vermont Center on Behavior and Health":MAILTO:Nicole.Twohig@uvm.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231213T120000
DTEND;TZID=America/New_York:20231213T130000
DTSTAMP:20260405T162649
CREATED:20231129T150827Z
LAST-MODIFIED:20231129T150827Z
UID:3305-1702468800-1702472400@www.ctnnortheastnode.org
SUMMARY:Evidence-Based Treatment of PTSD in Individuals with OUD\, and Innovative Approaches for Increasing Access to Care in Rural Communities
DESCRIPTION:This presentation will discuss effective treatment approaches for posttraumatic stress disorder (PTSD) in individuals with co-occurring opioid use disorder (OUD). It will also explore ways to increase access to evidence-based trauma treatment for members of rural communities. Register and attend to learn more! \nSpeaker:\nKelly Peck\, PhD\, Assistant Professor with joint appointments in the Departments of Psychiatry and Psychological Science at the University of Vermont (UVM) and the Director of Clinical Operations for the UVM Center on Rural Addiction (UVM CORA). \nRegister Now
URL:https://www.ctnnortheastnode.org/event/evidence-based-treatment-of-ptsd-in-individuals-with-oud-and-innovative-approaches-for-increasing-access-to-care-in-rural-communities/
CATEGORIES:Other Related
ORGANIZER;CN="UVM Center on Rural Addiction":MAILTO:CORA@uvm.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20231220T120000
DTEND;TZID=America/New_York:20231220T130000
DTSTAMP:20260405T162649
CREATED:20231130T221114Z
LAST-MODIFIED:20231130T221114Z
UID:3306-1703073600-1703077200@www.ctnnortheastnode.org
SUMMARY:The Changing World of Cannabis Consumption and Cannabis Regulation
DESCRIPTION:Vermont Center on Behavior and Health Monthly Lecture Series \nAlan Budney\, PhD\, Professor of Psychology\, Geisel School of Medicine at Dartmouth \nDr. Budney has conducted extensive research on the development and evaluation of innovative behavioral treatments for Cannabis Use Disorders in adults and adolescents. This programmatic research has focused on integrating innovative contingency management interventions with more traditional behavioral therapies and using computer-assisted therapies t enhance access to and theist effectiveness of these approaches. His recent work leverages social media enrollment strategies to assess the impact of impact of the changing legal landscape of cannabis\, to develop on-line interventions for cannabis use problems\, and to develop methods for accurately measuring cannabis consumption to inform more meaningful public health messaging out the potential negative and positive consequences of cannabis use. \nREGISTER FOR WEBINAR HERE
URL:https://www.ctnnortheastnode.org/event/the-changing-world-of-cannabis-consumption-and-cannabis-regulation/
CATEGORIES:Other Related
ORGANIZER;CN="UVM Vermont Center on Behavior and Health":MAILTO:Nicole.Twohig@uvm.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240220T110000
DTEND;TZID=America/New_York:20240220T120000
DTSTAMP:20260405T162649
CREATED:20240219T125208Z
LAST-MODIFIED:20240219T125208Z
UID:3312-1708426800-1708430400@www.ctnnortheastnode.org
SUMMARY:Collaborative Care Model (CoCM) for Substance Use Disorders
DESCRIPTION:Presenters: Anna Ratzliff\, MD\, PhD; Jasen Christensen\, DO \nWebinar Description \nThis presentation will review the Collaborative Care Model (CoCM)\, which is an evidence-based approach to delivering behavioral healthcare in primary care settings. This model has been adapted to address substance use disorders in primary medical settings. CoCM requires a team of providers; trained primary care providers (PCP) work with embedded behavioral health care managers (BHCM) to provide a range of effective treatments\, including evidence-based medication and/or psychosocial treatments\, and a psychiatric consultant who engages with the team primarily through indirect care. Implementation and clinical considerations for CoCM for substance use disorders will be reviewed. \nTarget Audience \nThis activity is designed for administrative staff\, counselors\, interprofessional teams\, nurses\, pharmacists\, pharmacy technicians\, physician assistants\, physicians\, psychiatrists\, psychologists\, social workers\, students and educators. This activity is accredited for physicians and other healthcare professionals. \nEducational Objectives \n\nDefine the need for substance use treatment in primary care settings.\nList evidence for Collaborative Care Model (CoCM) and usefulness in substance use disorder treatment.\nDescribe strategies to implement CoCM for substance use disorders.\nName clinical learning goals for teams to deliver CoCM for substance use disorders.\n\nRegister
URL:https://www.ctnnortheastnode.org/event/collaborative-care-model-cocm-for-substance-use-disorders/
CATEGORIES:Other Related
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240221T120000
DTEND;TZID=America/New_York:20240221T130000
DTSTAMP:20260405T162649
CREATED:20240202T004918Z
LAST-MODIFIED:20240202T004918Z
UID:3309-1708516800-1708520400@www.ctnnortheastnode.org
SUMMARY:Overdose-related Compassion Fatigue in Rural Communities
DESCRIPTION:Erin Winstanley\, PhD \nVisiting Professor\, University of Pittsburgh School of Medicine \n\n\n\n\n\nDr. Winstanley received her doctoral degree from The Johns Hopkins Bloomberg School of Public Health\, she has postdoctoral training in behavioral pharmacology\, and she has over 20 years of experience as a behavioral health services researcher. Dr. Winstanley’s current research is focused on reducing the morbidity and mortality associated with the overdose epidemic\, as well as the use of technology to improve access and quality of behavioral health services. She has expertise in rural health\, clinical trials\, patient-reported outcomes\, and health policy. Her work is committed to discovering and implementing evidence-based strategies to improve health outcomes for individuals with behavioral health problems. She is Co-Chair of the NIDA CTN Rural Special Interest Group (SIG)\, which is working to advance clinical research on substance use disorders in rural areas. \n\n\n\n\nREGISTER FOR WEBINAR HERE
URL:https://www.ctnnortheastnode.org/event/overdose-related-compassion-fatigue-in-rural-communities/
CATEGORIES:Other Related
ORGANIZER;CN="UVM Vermont Center on Behavior and Health":MAILTO:Nicole.Twohig@uvm.edu
END:VEVENT
END:VCALENDAR